The indication for anti-TNF therapy in Thailand’s JIA treatment guidelines is failure of two DMARDs within 6 months, which differs from the 2019 ACR treatment guideline for JIA (Ringold et al., 2019) for cost and other economic reasons. Here, TNF is linked to juvenile idiopathic arthritis.